| Dr Janet Petrucelli, MD | |
|
1 Degraw Ave, Teaneck, NJ 07666-4000 | |
| (201) 928-0200 | |
| (201) 928-0820 |
| Full Name | Dr Janet Petrucelli |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 22 Years |
| Location | 1 Degraw Ave, Teaneck, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154404358 | NPI | - | NPPES |
| 6818706 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | MA64903 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aspen Medical Associates, Pa | 5799738662 | 6 |
News Archive
Thanks to an exciting collaboration between the Queen Elizabeth Hospital Birmingham (QEHB), medical charity Cobalt and Siemens Healthineers, the pioneering Institute of Translational Medicine (ITM) will benefit from an innovative Magnetic Resonance Imaging (MRI) research facility, to be known as the ‘ITM Imaging Centre'.
Since the sequence map of the human genome, the cost of sequencing the genome of an individual has fallen rapidly. This has resulted in a tremendous increase in the amount of human genomic data available to the international research community for the advancement of biomedical research. Yet, there is an absence of international mechanisms to support researchers in ensuring ethical and legal interoperability. In addition, the multiplicity and diversity of laws, standards and policies on sharing and accessing genetic and medical data represent major hurdles to international collaboration.
Mylan Inc. has confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Hoffmann-La Roche Inc. in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Capecitabine Tablets, 150 mg and 500 mg, the generic version of Xeloda Tablets, a chemotherapy treatment for breast and colorectal cancer.
TaiGen Biotechnology Co., Ltd. announced today the Phase II trial of nemonoxacin (TG-873870) in Diabetic Foot Infection (DFI) with once-a-day dosing met the primary endpoints and showed promising clinical efficacy and good tolerability.
› Verified 3 days ago
| Entity Name | Aspen Medical Associates, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093848905 PECOS PAC ID: 5799738662 Enrollment ID: O20050303000056 |
News Archive
Thanks to an exciting collaboration between the Queen Elizabeth Hospital Birmingham (QEHB), medical charity Cobalt and Siemens Healthineers, the pioneering Institute of Translational Medicine (ITM) will benefit from an innovative Magnetic Resonance Imaging (MRI) research facility, to be known as the ‘ITM Imaging Centre'.
Since the sequence map of the human genome, the cost of sequencing the genome of an individual has fallen rapidly. This has resulted in a tremendous increase in the amount of human genomic data available to the international research community for the advancement of biomedical research. Yet, there is an absence of international mechanisms to support researchers in ensuring ethical and legal interoperability. In addition, the multiplicity and diversity of laws, standards and policies on sharing and accessing genetic and medical data represent major hurdles to international collaboration.
Mylan Inc. has confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Hoffmann-La Roche Inc. in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Capecitabine Tablets, 150 mg and 500 mg, the generic version of Xeloda Tablets, a chemotherapy treatment for breast and colorectal cancer.
TaiGen Biotechnology Co., Ltd. announced today the Phase II trial of nemonoxacin (TG-873870) in Diabetic Foot Infection (DFI) with once-a-day dosing met the primary endpoints and showed promising clinical efficacy and good tolerability.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Janet Petrucelli, MD 1 Degraw Ave, Teaneck, NJ 07666-4000 Ph: (201) 928-0200 | Dr Janet Petrucelli, MD 1 Degraw Ave, Teaneck, NJ 07666-4000 Ph: (201) 928-0200 |
News Archive
Thanks to an exciting collaboration between the Queen Elizabeth Hospital Birmingham (QEHB), medical charity Cobalt and Siemens Healthineers, the pioneering Institute of Translational Medicine (ITM) will benefit from an innovative Magnetic Resonance Imaging (MRI) research facility, to be known as the ‘ITM Imaging Centre'.
Since the sequence map of the human genome, the cost of sequencing the genome of an individual has fallen rapidly. This has resulted in a tremendous increase in the amount of human genomic data available to the international research community for the advancement of biomedical research. Yet, there is an absence of international mechanisms to support researchers in ensuring ethical and legal interoperability. In addition, the multiplicity and diversity of laws, standards and policies on sharing and accessing genetic and medical data represent major hurdles to international collaboration.
Mylan Inc. has confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Hoffmann-La Roche Inc. in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Capecitabine Tablets, 150 mg and 500 mg, the generic version of Xeloda Tablets, a chemotherapy treatment for breast and colorectal cancer.
TaiGen Biotechnology Co., Ltd. announced today the Phase II trial of nemonoxacin (TG-873870) in Diabetic Foot Infection (DFI) with once-a-day dosing met the primary endpoints and showed promising clinical efficacy and good tolerability.
› Verified 3 days ago
Mrs. Nancy Linda Muhlstock, P.T. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 94 Bennett Rd., Teaneck, NJ 07666 Phone: 201-837-8764 Fax: 201-862-0607 | |
Dimir Abrar, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1 Degraw Ave, Teaneck, NJ 07666 Phone: 201-928-0200 | |
Dr. Christine Pfisterer, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 870 Palisade Ave, Suite #205, Teaneck, NJ 07666 Phone: 201-836-1663 Fax: 201-836-5729 | |
Dr. Tuan Nguyen, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1 Degraw Ave, Teaneck, NJ 07666 Phone: 201-928-0200 Fax: 201-928-0820 | |
Michal R Sheps, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1 Degraw Ave, Teaneck, NJ 07666 Phone: 201-928-0200 Fax: 201-928-0814 | |
Dr. Anjali Sinha, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: Aspen Medical Associates, 1 Degraw Ave, Teaneck, NJ 07666 Phone: 201-928-0200 |